RB
Therapeutic Areas
Collegium Pharmaceutical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Portfolio of Pain Products | Severe and persistent pain | Approved/Commercial |
| JORNAY PM | Attention-Deficit/Hyperactivity Disorder (ADHD) | Approved/Commercial |
| AZSTARYS | Attention-Deficit/Hyperactivity Disorder (ADHD) | Approved/Commercial |
Leadership Team at Collegium Pharmaceutical
VK
Vikram Karnani
President & Chief Executive Officer
DD
David Dieter
Executive Vice President, General Counsel
SD
Scott Dreyer
Executive Vice President, Chief Commercial Officer
JG
Jane Gonnerman
Executive Vice President, Strategy & Corporate Development
DJ
Dean J. Patras
Chief People Officer
CT
Colleen Tupper
Executive Vice President, Chief Financial Officer
TS
Thomas Smith, M.D.
Executive Vice President, Chief Medical Officer
SS
Scott Sudduth
Executive Vice President, Head of Technical Operations
GS
Gino Santini
Chairman of the Board
GB
Garen Bohlin
Director